These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28303314)

  • 1. [Genetic tests for controlling treatment with antidepressants].
    Bschor T; Baethge C; Hiemke C; Müller-Oerlinghausen B
    Nervenarzt; 2017 May; 88(5):495-499. PubMed ID: 28303314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressants].
    Jeleń A; Sałagacka A; Balcerczak E
    Postepy Hig Med Dosw (Online); 2015 Jul; 69():753-62. PubMed ID: 26206991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.
    Fabbri C; Serretti A
    Curr Psychiatry Rep; 2015 Jul; 17(7):50. PubMed ID: 25980509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic considerations for current state-of-the-art antidepressants.
    Wyska E
    Expert Opin Drug Metab Toxicol; 2019 Oct; 15(10):831-847. PubMed ID: 31526279
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenomic testing and personalized treatment of depression.
    Perlis RH
    Clin Chem; 2014 Jan; 60(1):53-9. PubMed ID: 24281779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.
    Eap CB; Jaquenoud Sirot E; Baumann P
    Ther Drug Monit; 2004 Apr; 26(2):152-5. PubMed ID: 15228156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics: the therapeutic drug monitoring of the future?
    Ensom MH; Chang TK; Patel P
    Clin Pharmacokinet; 2001; 40(11):783-802. PubMed ID: 11735602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials.
    Fabbri C; Zohar J; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():36-44. PubMed ID: 29777729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
    Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM
    CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.
    Sjöqvist F; Eliasson E
    Clin Pharmacol Ther; 2007 Jun; 81(6):899-902. PubMed ID: 17392719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.
    Porcelli S; Fabbri C; Spina E; Serretti A; De Ronchi D
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1101-15. PubMed ID: 21736534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of antidepressants and cytochrome p450 genotyping in general practice.
    Kootstra-Ros JE; Van Weelden MJ; Hinrichs JW; De Smet PA; van der Weide J
    J Clin Pharmacol; 2006 Nov; 46(11):1320-7. PubMed ID: 17050797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine.
    Nassan M; Nicholson WT; Elliott MA; Rohrer Vitek CR; Black JL; Frye MA
    Mayo Clin Proc; 2016 Jul; 91(7):897-907. PubMed ID: 27289413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roadmap for Routine Pharmacogenetic Testing in a Psychiatric University Hospital.
    Menke A; Weber H; Deckert J
    Pharmacopsychiatry; 2020 Jul; 53(4):179-183. PubMed ID: 31185510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.
    Burke MJ; Preskorn SH
    Clin Pharmacokinet; 1999 Aug; 37(2):147-65. PubMed ID: 10496302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of pharmacogenetic tests in antidepressive medication therapy].
    Kirchheiner J; Sasse J; Roots I; Brockmöller J; Bauer M
    Nervenarzt; 2005 Nov; 76(11):1340-54. PubMed ID: 15864514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic testing among patients with depression in a US managed care population.
    Anderson HD; Thant TM; Kao DP; Crooks KR; Mendola ND; Aquilante CL
    Clin Transl Sci; 2022 Jul; 15(7):1644-1653. PubMed ID: 35385214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.